MOONLAKE IMMUNOTHERAPEUTICS (MLTX)
Clinical trial NCT06411379 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-06-17 → 2026-05-20 3. primary completion date: 2025-06-17 → 2025-08-14
Clinical trial NCT06411379 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-06-17 → 2026-05-20 3. primary completion date: 2025-06-17 → 2025-08-14
📉 **NEGATIVE** • Medium confidence analysis (67%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical